163 related articles for article (PubMed ID: 19885545)
21. MyD88, IRAK1 and TRAF6 knockdown in human chondrocytes inhibits interleukin-1-induced matrix metalloproteinase-13 gene expression and promoter activity by impairing MAP kinase activation.
Ahmad R; Sylvester J; Zafarullah M
Cell Signal; 2007 Dec; 19(12):2549-57. PubMed ID: 17905570
[TBL] [Abstract][Full Text] [Related]
22. Platelet-activating factor overturns the transcriptional repressor disposition of Sp1 in the expression of MMP-9 in human corneal epithelial cells.
Taheri F; Bazan HE
Invest Ophthalmol Vis Sci; 2007 May; 48(5):1931-41. PubMed ID: 17460244
[TBL] [Abstract][Full Text] [Related]
23. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: Involvement of the ras dependent pathway.
Moon SK; Cha BY; Kim CH
J Cell Physiol; 2004 Mar; 198(3):417-27. PubMed ID: 14755547
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of matrix metalloproteinase-1 expression in U937 cells by low-density lipoprotein-containing immune complexes requires the activator protein-1 and the Ets motifs in the distal and the proximal promoter regions.
Maldonado A; Game BA; Song L; Huang Y
Immunology; 2003 Aug; 109(4):572-9. PubMed ID: 12871225
[TBL] [Abstract][Full Text] [Related]
25. Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells.
Kim SY; Kim DH; Han SJ; Hyun JW; Kim HS
Biochem Pharmacol; 2007 Dec; 74(11):1642-51. PubMed ID: 17880928
[TBL] [Abstract][Full Text] [Related]
26. MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-beta in rat mesangial cells.
Guo B; Inoki K; Isono M; Mori H; Kanasaki K; Sugimoto T; Akiba S; Sato T; Yang B; Kikkawa R; Kashiwagi A; Haneda M; Koya D
Kidney Int; 2005 Sep; 68(3):972-84. PubMed ID: 16105028
[TBL] [Abstract][Full Text] [Related]
27. Ataxia-telangiectasia group D complementing gene (ATDC) upregulates matrix metalloproteinase 9 (MMP-9) to promote lung cancer cell invasion by activating ERK and JNK pathways.
Tang ZP; Cui QZ; Dong QZ; Xu K; Wang EH
Tumour Biol; 2013 Oct; 34(5):2835-42. PubMed ID: 23681803
[TBL] [Abstract][Full Text] [Related]
28. The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation.
Simon C; Simon M; Vucelic G; Hicks MJ; Plinkert PK; Koitschev A; Zenner HP
Exp Cell Res; 2001 Dec; 271(2):344-55. PubMed ID: 11716547
[TBL] [Abstract][Full Text] [Related]
29. Tetraspanin CD9 induces MMP-2 expression by activating p38 MAPK, JNK and c-Jun pathways in human melanoma cells.
Hong IK; Kim YM; Jeoung DI; Kim KC; Lee H
Exp Mol Med; 2005 Jun; 37(3):230-9. PubMed ID: 16000878
[TBL] [Abstract][Full Text] [Related]
30. Redox-dependent matrix metalloproteinase-1 expression is regulated by JNK through Ets and AP-1 promoter motifs.
Nelson KK; Subbaram S; Connor KM; Dasgupta J; Ha XF; Meng TC; Tonks NK; Melendez JA
J Biol Chem; 2006 May; 281(20):14100-10. PubMed ID: 16569638
[TBL] [Abstract][Full Text] [Related]
31. Cordycepin inhibits IL-1beta-induced MMP-1 and MMP-3 expression in rheumatoid arthritis synovial fibroblasts.
Noh EM; Kim JS; Hur H; Park BH; Song EK; Han MK; Kwon KB; Yoo WH; Shim IK; Lee SJ; Youn HJ; Lee YR
Rheumatology (Oxford); 2009 Jan; 48(1):45-8. PubMed ID: 19056796
[TBL] [Abstract][Full Text] [Related]
32. Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells.
Chen HJ; Lin CM; Lee CY; Shih NC; Peng SF; Tsuzuki M; Amagaya S; Huang WW; Yang JS
Oncol Rep; 2013 Aug; 30(2):925-32. PubMed ID: 23708932
[TBL] [Abstract][Full Text] [Related]
33. Involvement of JNK-AP-1 and ERK-NF-κB signaling in tension-stimulated expression of type I collagen and MMP-1 in human periodontal ligament fibroblasts.
Kook SH; Jang YS; Lee JC
J Appl Physiol (1985); 2011 Dec; 111(6):1575-83. PubMed ID: 21757573
[TBL] [Abstract][Full Text] [Related]
34. CADPE inhibits PMA-stimulated gastric carcinoma cell invasion and matrix metalloproteinase-9 expression by FAK/MEK/ERK-mediated AP-1 activation.
Han H; Du B; Pan X; Liu J; Zhao Q; Lian X; Qian M; Liu M
Mol Cancer Res; 2010 Nov; 8(11):1477-88. PubMed ID: 21047770
[TBL] [Abstract][Full Text] [Related]
35. FGF-1-induced matrix metalloproteinase-9 expression in breast cancer cells is mediated by increased activities of NF-kappaB and activating protein-1.
Lungu G; Covaleda L; Mendes O; Martini-Stoica H; Stoica G
Mol Carcinog; 2008 Jun; 47(6):424-35. PubMed ID: 18041768
[TBL] [Abstract][Full Text] [Related]
36. Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1).
Endres M; Kneitz S; Orth MF; Perera RK; Zernecke A; Butt E
Oncotarget; 2016 Sep; 7(39):64244-64259. PubMed ID: 27588391
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase-3 induction in rat brain astrocytes: focus on the role of two AP-1 elements.
Kim KS; Kim HY; Joe EH; Jou I
Biochem J; 2008 Mar; 410(3):605-11. PubMed ID: 18072934
[TBL] [Abstract][Full Text] [Related]
38. Antitumor effects of the novel quinazolinone MJ-33: inhibition of metastasis through the MAPK, AKT, NF-κB and AP-1 signaling pathways in DU145 human prostate cancer cells.
Hour MJ; Tsai SC; Wu HC; Lin MW; Chung JG; Wu JB; Chiang JH; Tsuzuki M; Yang JS
Int J Oncol; 2012 Oct; 41(4):1513-9. PubMed ID: 22825655
[TBL] [Abstract][Full Text] [Related]
39. Chrysin inhibits tumor promoter-induced MMP-9 expression by blocking AP-1 via suppression of ERK and JNK pathways in gastric cancer cells.
Xia Y; Lian S; Khoi PN; Yoon HJ; Joo YE; Chay KO; Kim KK; Do Jung Y
PLoS One; 2015; 10(4):e0124007. PubMed ID: 25875631
[TBL] [Abstract][Full Text] [Related]
40. Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways.
Chang MC; Chen CA; Chen PJ; Chiang YC; Chen YL; Mao TL; Lin HW; Lin Chiang WH; Cheng WF
Biochem J; 2012 Mar; 442(2):293-302. PubMed ID: 21999204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
